select trial semaglutide study Cardiovascular Information The talk is often focussed – SELECT trial shows cardiovascular risk

Melanocortin 1 Receptor: Structure, Function, and Regulation

An analysis published this week in JAMA Internal Medicine found that most participants in a clinical trial who were assigned to stop taking tirzepatide (Zepbound from Eli Lilly) not only regained significant amounts of the weight they had lost on the drug, but they also saw their cardiovascular and metabolic improvements slip away

There is currently no approved generic Ozempic (semaglutide)

Therefore, further large-scale, prospective research is essential to refine these guidelines, ensure individualized patient safety, and improve overall perioperative outcomes

Should incretin therapies receive regulatory approval for alcohol use disorder, their pre-existing acceptance and broad use could substantially increase treatment access, reducing conventional treatment barriers. Alcohol use disorder accounts for five per cent of deaths worldwide annually, and there is an urgent need for new treatments

Foods, 11 (3)